ID   AMACR_HUMAN             Reviewed;         382 AA.
AC   Q9UHK6; A5YM47; B8Y916; B8Y918; F8W9N1; O43673; Q3KT79; Q96GH1;
AC   Q9Y3Q1;
DT   27-APR-2001, integrated into UniProtKB/Swiss-Prot.
DT   30-NOV-2010, sequence version 2.
DT   12-APR-2017, entry version 153.
DE   RecName: Full=Alpha-methylacyl-CoA racemase;
DE            EC=5.1.99.4;
DE   AltName: Full=2-methylacyl-CoA racemase;
GN   Name=AMACR;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), VARIANTS ASP-175; SER-201;
RP   THR-261 AND LYS-277, SUBCELLULAR LOCATION, AND MICROBODY TARGETING.
RX   PubMed=11060344;
RA   Amery L., Fransen M., De Nys K., Mannaerts G.P., Van Veldhoven P.P.;
RT   "Mitochondrial and peroxisomal targeting of 2-methylacyl-CoA racemase
RT   in humans.";
RL   J. Lipid Res. 41:1752-1759(2000).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), VARIANT AMACRD PRO-52, VARIANT
RP   CBAS4 PRO-107, VARIANTS SER-201 AND LYS-277, CHARACTERIZATION OF
RP   VARIANT AMACRD PRO-52, AND CHARACTERIZATION OF VARIANT CBAS4 PRO-107.
RX   PubMed=10655068; DOI=10.1038/72861;
RA   Ferdinandusse S., Denis S., Clayton P.T., Graham A., Rees J.E.,
RA   Allen J.T., McLean B.N., Brown A.Y., Vreken P., Waterham H.R.,
RA   Wanders R.J.A.;
RT   "Mutations in the gene encoding peroxisomal alpha-methylacyl-CoA
RT   racemase cause adult-onset sensory motor neuropathy.";
RL   Nat. Genet. 24:188-191(2000).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 4), AND VARIANTS SER-201 AND
RP   LYS-277.
RC   TISSUE=Prostate cancer;
RX   PubMed=15880524; DOI=10.1002/pros.20277;
RA   Mubiru J.N., Valente A.J., Troyer D.A.;
RT   "A variant of the alpha-methyl-acyl-CoA racemase gene created by a
RT   deletion in exon 5 and its expression in prostate cancer.";
RL   Prostate 65:117-123(2005).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND VARIANTS MET-9; ASP-175;
RP   SER-201; THR-261 AND LYS-277.
RA   Albers C., Schmitz W., Conzelmann E.;
RT   "Human alpha-methylacyl-CoA racemase cDNA sequence.";
RL   Submitted (JAN-1999) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2), AND VARIANT MET-9.
RA   Ouyang B., Leung Y.-K., Wang V., Chung E., Levin L., Bracken B.,
RA   Cheng L., Ho S.-M.;
RT   "Expression of alpha-methylacyl-CoA racemase spliced variants in
RT   normal and malignant prostate tissue.";
RL   Submitted (NOV-2008) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3), AND VARIANT MET-9.
RA   Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S.,
RA   Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y.,
RA   Phelan M., Farmer A.;
RT   "Cloning of human full-length CDSs in BD Creator(TM) system donor
RT   vector.";
RL   Submitted (MAY-2003) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Salivary gland;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H.,
RA   Heubner D., Hoerlein A., Michel G., Wedler H., Koehrer K.,
RA   Ottenwaelder B., Poustka A., Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15372022; DOI=10.1038/nature02919;
RA   Schmutz J., Martin J., Terry A., Couronne O., Grimwood J., Lowry S.,
RA   Gordon L.A., Scott D., Xie G., Huang W., Hellsten U., Tran-Gyamfi M.,
RA   She X., Prabhakar S., Aerts A., Altherr M., Bajorek E., Black S.,
RA   Branscomb E., Caoile C., Challacombe J.F., Chan Y.M., Denys M.,
RA   Detter J.C., Escobar J., Flowers D., Fotopulos D., Glavina T.,
RA   Gomez M., Gonzales E., Goodstein D., Grigoriev I., Groza M.,
RA   Hammon N., Hawkins T., Haydu L., Israni S., Jett J., Kadner K.,
RA   Kimball H., Kobayashi A., Lopez F., Lou Y., Martinez D., Medina C.,
RA   Morgan J., Nandkeshwar R., Noonan J.P., Pitluck S., Pollard M.,
RA   Predki P., Priest J., Ramirez L., Retterer J., Rodriguez A.,
RA   Rogers S., Salamov A., Salazar A., Thayer N., Tice H., Tsai M.,
RA   Ustaszewska A., Vo N., Wheeler J., Wu K., Yang J., Dickson M.,
RA   Cheng J.-F., Eichler E.E., Olsen A., Pennacchio L.A., Rokhsar D.S.,
RA   Richardson P., Lucas S.M., Myers R.M., Rubin E.M.;
RT   "The DNA sequence and comparative analysis of human chromosome 5.";
RL   Nature 431:268-274(2004).
RN   [9]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA], AND VARIANT MET-9.
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [10]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3), AND VARIANT MET-9.
RC   TISSUE=Kidney;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [11]
RP   CHARACTERIZATION.
RC   TISSUE=Liver;
RX   PubMed=7649182; DOI=10.1111/j.1432-1033.1995.tb20766.x;
RA   Schmitz W., Albers C., Fingerhut R., Conzelmann E.;
RT   "Purification and characterization of an alpha-methylacyl-CoA racemase
RT   from human liver.";
RL   Eur. J. Biochem. 231:815-822(1995).
RN   [12]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [13]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [14]
RP   VARIANT CBAS4 PRO-52.
RX   PubMed=12512044; DOI=10.1053/gast.2003.50017;
RA   Setchell K.D.R., Heubi J.E., Bove K.E., O'Connell N.C., Brewsaugh T.,
RA   Steinberg S.J., Moser A., Squires R.H. Jr.;
RT   "Liver disease caused by failure to racemize trihydroxycholestanoic
RT   acid: gene mutation and effect of bile acid therapy.";
RL   Gastroenterology 124:217-232(2003).
CC   -!- FUNCTION: Racemization of 2-methyl-branched fatty acid CoA esters.
CC       Responsible for the conversion of pristanoyl-CoA and C27-bile
CC       acyl-CoAs to their (S)-stereoisomers.
CC   -!- CATALYTIC ACTIVITY: (2S)-2-methylacyl-CoA = (2R)-2-methylacyl-CoA.
CC   -!- PATHWAY: Lipid metabolism; bile acid biosynthesis.
CC   -!- PATHWAY: Lipid metabolism; fatty acid metabolism.
CC   -!- SUBCELLULAR LOCATION: Peroxisome {ECO:0000269|PubMed:11060344}.
CC       Mitochondrion {ECO:0000269|PubMed:11060344}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=4;
CC       Name=1;
CC         IsoId=Q9UHK6-1; Sequence=Displayed;
CC       Name=2; Synonyms=IBLi;
CC         IsoId=Q9UHK6-2; Sequence=VSP_037321, VSP_037326;
CC         Note=May be produced at very low levels due to a premature stop
CC         codon in the mRNA, leading to nonsense-mediated mRNA decay.;
CC       Name=3;
CC         IsoId=Q9UHK6-4; Sequence=VSP_037323, VSP_037324;
CC       Name=4;
CC         IsoId=Q9UHK6-5; Sequence=VSP_044875;
CC         Note=Expression is elevated in prostate cancer.;
CC   -!- DISEASE: Alpha-methylacyl-CoA racemase deficiency (AMACRD)
CC       [MIM:614307]: A rare autosomal recessive peroxisomal disorder
CC       characterized by elevated plasma concentrations of pristanic acid
CC       C27-bile-acid intermediates, and adult onset of variable
CC       neurodegenerative symptoms affecting the central and peripheral
CC       nervous systems. Features may include seizures, visual failure,
CC       sensorimotor neuropathy, spasticity, migraine, and white matter
CC       hyperintensities on brain imaging. {ECO:0000269|PubMed:10655068}.
CC       Note=The disease is caused by mutations affecting the gene
CC       represented in this entry.
CC   -!- DISEASE: Congenital bile acid synthesis defect 4 (CBAS4)
CC       [MIM:214950]: A disorder characterized by the presence of
CC       trihydroxycoprostanic acid in the bile and absence of cholic acid.
CC       Patients manifest neonatal jaundice, intrahepatic cholestasis and
CC       bile duct deficiency. {ECO:0000269|PubMed:10655068,
CC       ECO:0000269|PubMed:12512044}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the CaiB/BaiF CoA-transferase family.
CC       {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=ACL67853.1; Type=Miscellaneous discrepancy; Note=Aberrant splicing.; Evidence={ECO:0000305};
CC       Sequence=ACL67854.1; Type=Miscellaneous discrepancy; Note=Aberrant splicing.; Evidence={ECO:0000305};
CC       Sequence=CAB44062.1; Type=Frameshift; Positions=62, 65, 114; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AJ130733; CAB44062.1; ALT_FRAME; mRNA.
DR   EMBL; AF158378; AAF22610.1; -; mRNA.
DR   EMBL; AY935981; AAY16192.1; -; mRNA.
DR   EMBL; AF047020; AAD10205.1; -; mRNA.
DR   EMBL; FJ498906; ACL67853.1; ALT_SEQ; mRNA.
DR   EMBL; FJ498907; ACL67854.1; ALT_SEQ; mRNA.
DR   EMBL; FJ498908; ACL67855.1; -; mRNA.
DR   EMBL; BT007193; AAP35857.1; -; mRNA.
DR   EMBL; EF560721; ABQ59031.1; -; mRNA.
DR   EMBL; AC139783; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471118; EAX10816.1; -; Genomic_DNA.
DR   EMBL; BC009471; AAH09471.1; -; mRNA.
DR   CCDS; CCDS3902.1; -. [Q9UHK6-1]
DR   CCDS; CCDS3903.1; -. [Q9UHK6-4]
DR   CCDS; CCDS54836.1; -. [Q9UHK6-5]
DR   RefSeq; NP_001161067.1; NM_001167595.1. [Q9UHK6-5]
DR   RefSeq; NP_055139.4; NM_014324.5. [Q9UHK6-1]
DR   RefSeq; NP_976316.1; NM_203382.2. [Q9UHK6-4]
DR   UniGene; Hs.508343; -.
DR   ProteinModelPortal; Q9UHK6; -.
DR   SMR; Q9UHK6; -.
DR   BioGrid; 117134; 6.
DR   STRING; 9606.ENSP00000371517; -.
DR   SwissLipids; SLP:000001289; -.
DR   iPTMnet; Q9UHK6; -.
DR   PhosphoSitePlus; Q9UHK6; -.
DR   BioMuta; AMACR; -.
DR   DMDM; 313104070; -.
DR   EPD; Q9UHK6; -.
DR   PaxDb; Q9UHK6; -.
DR   PeptideAtlas; Q9UHK6; -.
DR   PRIDE; Q9UHK6; -.
DR   DNASU; 23600; -.
DR   Ensembl; ENST00000335606; ENSP00000334424; ENSG00000242110. [Q9UHK6-1]
DR   Ensembl; ENST00000382072; ENSP00000371504; ENSG00000242110. [Q9UHK6-4]
DR   Ensembl; ENST00000382085; ENSP00000371517; ENSG00000242110. [Q9UHK6-5]
DR   Ensembl; ENST00000506639; ENSP00000427227; ENSG00000242110. [Q9UHK6-2]
DR   GeneID; 23600; -.
DR   KEGG; hsa:23600; -.
DR   UCSC; uc003jig.4; human. [Q9UHK6-1]
DR   CTD; 23600; -.
DR   DisGeNET; 23600; -.
DR   GeneCards; AMACR; -.
DR   HGNC; HGNC:451; AMACR.
DR   HPA; CAB001809; -.
DR   HPA; HPA019527; -.
DR   HPA; HPA020912; -.
DR   MalaCards; AMACR; -.
DR   MIM; 214950; phenotype.
DR   MIM; 604489; gene.
DR   MIM; 614307; phenotype.
DR   neXtProt; NX_Q9UHK6; -.
DR   OpenTargets; ENSG00000242110; -.
DR   Orphanet; 79095; Congenital bile acid synthesis defect type 4.
DR   PharmGKB; PA24757; -.
DR   eggNOG; KOG3957; Eukaryota.
DR   eggNOG; COG1804; LUCA.
DR   GeneTree; ENSGT00530000063418; -.
DR   HOGENOM; HOG000219744; -.
DR   HOVERGEN; HBG060891; -.
DR   InParanoid; Q9UHK6; -.
DR   KO; K01796; -.
DR   OMA; GSHDLNY; -.
DR   OrthoDB; EOG091G0FPV; -.
DR   PhylomeDB; Q9UHK6; -.
DR   TreeFam; TF314188; -.
DR   BioCyc; MetaCyc:HS01416-MONOMER; -.
DR   BRENDA; 5.1.99.4; 2681.
DR   Reactome; R-HSA-193368; Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol.
DR   Reactome; R-HSA-193775; Synthesis of bile acids and bile salts via 24-hydroxycholesterol.
DR   Reactome; R-HSA-389887; Beta-oxidation of pristanoyl-CoA.
DR   SABIO-RK; Q9UHK6; -.
DR   UniPathway; UPA00199; -.
DR   UniPathway; UPA00221; -.
DR   ChiTaRS; AMACR; human.
DR   GeneWiki; Alpha-methylacyl-CoA_racemase; -.
DR   GenomeRNAi; 23600; -.
DR   PRO; PR:Q9UHK6; -.
DR   Proteomes; UP000005640; Chromosome 5.
DR   Bgee; ENSG00000242110; -.
DR   CleanEx; HS_AMACR; -.
DR   ExpressionAtlas; Q9UHK6; baseline and differential.
DR   Genevisible; Q9UHK6; HS.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0043231; C:intracellular membrane-bounded organelle; IDA:HPA.
DR   GO; GO:0005739; C:mitochondrion; IDA:UniProtKB.
DR   GO; GO:0005782; C:peroxisomal matrix; TAS:Reactome.
DR   GO; GO:0005777; C:peroxisome; IDA:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; IDA:HPA.
DR   GO; GO:0008111; F:alpha-methylacyl-CoA racemase activity; IDA:UniProtKB.
DR   GO; GO:0005102; F:receptor binding; IPI:UniProtKB.
DR   GO; GO:0006699; P:bile acid biosynthetic process; TAS:Reactome.
DR   GO; GO:0008206; P:bile acid metabolic process; IDA:UniProtKB.
DR   GO; GO:0033540; P:fatty acid beta-oxidation using acyl-CoA oxidase; TAS:Reactome.
DR   Gene3D; 3.40.50.10540; -; 1.
DR   InterPro; IPR003673; CoA-Trfase_fam_III.
DR   InterPro; IPR023606; CoA-Trfase_III_dom.
DR   Pfam; PF02515; CoA_transf_3; 1.
DR   SUPFAM; SSF89796; SSF89796; 1.
PE   1: Evidence at protein level;
KW   Acetylation; Alternative splicing; Complete proteome;
KW   Disease mutation; Intrahepatic cholestasis; Isomerase; Mitochondrion;
KW   Peroxisome; Polymorphism; Reference proteome.
FT   INIT_MET      1      1       Removed. {ECO:0000250|UniProtKB:O09174}.
FT   CHAIN         2    382       Alpha-methylacyl-CoA racemase.
FT                                /FTId=PRO_0000194705.
FT   MOTIF       380    382       Microbody targeting signal.
FT   ACT_SITE    152    152       Nucleophile. {ECO:0000250}.
FT   MOD_RES      58     58       N6-acetyllysine.
FT                                {ECO:0000250|UniProtKB:O09174}.
FT   MOD_RES      87     87       N6-acetyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:O09174}.
FT   MOD_RES      87     87       N6-succinyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:O09174}.
FT   MOD_RES     268    268       N6-succinyllysine.
FT                                {ECO:0000250|UniProtKB:O09174}.
FT   VAR_SEQ     132    229       VLSKIGRSGENPYAPLNLLADFAGGGLMCALGIIMALFDRT
FT                                RTGKGQVIDANMVEGTAYLSSFLWKTQKLSLWEAPRGQNML
FT                                DGGAPFYTTYRTADGE -> GRNSIFKFFSVENSEIESVGS
FT                                TSRTEHVGWWSTFLYDLQDSRWGIHGCWSNRTPVLRAADQR
FT                                SLIPYFNLYLQFLNISMQNLFKVHTLLRPCYFLGQK (in
FT                                isoform 2). {ECO:0000303|Ref.5}.
FT                                /FTId=VSP_037321.
FT   VAR_SEQ     132    198       VLSKIGRSGENPYAPLNLLADFAGGGLMCALGIIMALFDRT
FT                                RTGKGQVIDANMVEGTAYLSSFLWKT -> GRNSIFKFFSV
FT                                ENSEIESVGSTSRTEHVGWWSTFLYDLQDSRWGIHGCWSNR
FT                                TPVLRAADQRTWTKV (in isoform 3).
FT                                {ECO:0000303|PubMed:15489334,
FT                                ECO:0000303|Ref.6}.
FT                                /FTId=VSP_037323.
FT   VAR_SEQ     199    382       Missing (in isoform 3).
FT                                {ECO:0000303|PubMed:15489334,
FT                                ECO:0000303|Ref.6}.
FT                                /FTId=VSP_037324.
FT   VAR_SEQ     230    382       Missing (in isoform 2).
FT                                {ECO:0000303|Ref.5}.
FT                                /FTId=VSP_037326.
FT   VAR_SEQ     378    382       VKASL -> AGSKFWILYPTHSNIQK (in isoform
FT                                4). {ECO:0000303|PubMed:15880524}.
FT                                /FTId=VSP_044875.
FT   VARIANT       9      9       V -> M (in dbSNP:rs3195676).
FT                                {ECO:0000269|PubMed:15489334,
FT                                ECO:0000269|Ref.4, ECO:0000269|Ref.5,
FT                                ECO:0000269|Ref.6, ECO:0000269|Ref.9}.
FT                                /FTId=VAR_010660.
FT   VARIANT      52     52       S -> P (in AMACRD and CBAS4; inactive
FT                                enzyme; dbSNP:rs121917814).
FT                                {ECO:0000269|PubMed:10655068,
FT                                ECO:0000269|PubMed:12512044}.
FT                                /FTId=VAR_010661.
FT   VARIANT     107    107       L -> P (in CBAS4; inactive enzyme;
FT                                dbSNP:rs121917816).
FT                                {ECO:0000269|PubMed:10655068}.
FT                                /FTId=VAR_010665.
FT   VARIANT     118    118       R -> Q (in dbSNP:rs16892150).
FT                                /FTId=VAR_055616.
FT   VARIANT     175    175       G -> D (in dbSNP:rs10941112).
FT                                {ECO:0000269|PubMed:11060344,
FT                                ECO:0000269|Ref.4}.
FT                                /FTId=VAR_010662.
FT   VARIANT     201    201       L -> S (in dbSNP:rs2287939).
FT                                {ECO:0000269|PubMed:10655068,
FT                                ECO:0000269|PubMed:11060344,
FT                                ECO:0000269|PubMed:15880524,
FT                                ECO:0000269|Ref.4}.
FT                                /FTId=VAR_010663.
FT   VARIANT     238    238       P -> S (in dbSNP:rs9282594).
FT                                /FTId=VAR_055617.
FT   VARIANT     239    239       Q -> H (in dbSNP:rs34677).
FT                                /FTId=VAR_055618.
FT   VARIANT     261    261       M -> I (in dbSNP:rs9282593).
FT                                /FTId=VAR_055619.
FT   VARIANT     261    261       M -> T (in dbSNP:rs3195678).
FT                                {ECO:0000269|PubMed:11060344,
FT                                ECO:0000269|Ref.4}.
FT                                /FTId=VAR_055620.
FT   VARIANT     277    277       E -> K (in dbSNP:rs2278008).
FT                                {ECO:0000269|PubMed:10655068,
FT                                ECO:0000269|PubMed:11060344,
FT                                ECO:0000269|PubMed:15880524,
FT                                ECO:0000269|Ref.4}.
FT                                /FTId=VAR_010664.
FT   CONFLICT     18     18       P -> R (in Ref. 1; CAB44062).
FT                                {ECO:0000305}.
FT   CONFLICT    128    128       A -> T (in Ref. 7; ABQ59031).
FT                                {ECO:0000305}.
FT   CONFLICT    150    150       L -> V (in Ref. 1; CAB44062).
FT                                {ECO:0000305}.
FT   CONFLICT    183    183       N -> D (in Ref. 4; AAD10205).
FT                                {ECO:0000305}.
FT   CONFLICT    257    257       N -> S (in Ref. 4; AAD10205).
FT                                {ECO:0000305}.
FT   CONFLICT    327    327       P -> L (in Ref. 1; CAB44062).
FT                                {ECO:0000305}.
FT   CONFLICT    340    342       FKR -> SKG (in Ref. 1; CAB44062).
FT                                {ECO:0000305}.
SQ   SEQUENCE   382 AA;  42387 MW;  E967D3221A90BEF8 CRC64;
     MALQGISVVE LSGLAPGPFC AMVLADFGAR VVRVDRPGSR YDVSRLGRGK RSLVLDLKQP
     RGAAVLRRLC KRSDVLLEPF RRGVMEKLQL GPEILQRENP RLIYARLSGF GQSGSFCRLA
     GHDINYLALS GVLSKIGRSG ENPYAPLNLL ADFAGGGLMC ALGIIMALFD RTRTGKGQVI
     DANMVEGTAY LSSFLWKTQK LSLWEAPRGQ NMLDGGAPFY TTYRTADGEF MAVGAIEPQF
     YELLIKGLGL KSDELPNQMS MDDWPEMKKK FADVFAEKTK AEWCQIFDGT DACVTPVLTF
     EEVVHHDHNK ERGSFITSEE QDVSPRPAPL LLNTPAIPSF KRDPFIGEHT EEILEEFGFS
     REEIYQLNSD KIIESNKVKA SL
//
